ENTPD1 and melanoma: Together, these multidimensional interactions complete the immunosuppressive framework driven by CD39+PD-1+ Tregs, providing a mechanistic basis for their role in shaping TME composition, driving immune evasion, and contributing to immunotherapy resistance in melanoma.